| Dr Jonathan Lee Wilson, MD | |
|
4141 5th St, Rapid City, SD 57701-6021 | |
| (605) 341-2424 | |
| (605) 341-4547 |
| Full Name | Dr Jonathan Lee Wilson |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 17 Years |
| Location | 4141 5th St, Rapid City, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376727354 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 8806 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Davie Medical Center | Mocksville, NC | Hospital |
| North Carolina Baptist Hospital | Winston-salem, NC | Hospital |
| Lexington Memorial Hospital Inc | Lexington, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wake Forest University Health Sciences | 4486564952 | 1987 |
News Archive
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that diluted earnings per share equaled $0.39 in the first quarter of fiscal 2011. Excluding the charge related to the United States Department of Justice investigations described below, and a charge of $50.0 million, or $0.17 per share net of tax, for a new product licensing fee, non-GAAP earnings per share for the first fiscal quarter were $0.95 per share.
Humana Inc. alleges the device maker violated federal racketeering statutes by conspiring with prominent physicians to promote unapproved uses of the drug, reports The Wall Street Journal.
One of the problems faced by health officials today is the vast number of asymptomatic carriers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as they can still transmit the virus. Therefore the testing of as many people as possible is crucial for immediate isolation of cases to prevent the virus from spreading further.
The WHO and Roll Back Malaria partnership (RBM) on Wednesday launched an initiative to "stop a form of drug-resistant malaria from spreading from Southeast Asia to Africa, where millions of lives could be at risk," Reuters reports. "It would cost about $175 million a year to contain and prevent the global spread of the artemisinin-resistant parasite which first emerged along the Thai-Cambodian border in 2007, the United Nations agency said," according to the news agency (Nebehay, 1/12).
› Verified 3 days ago
| Entity Name | Wake Forest University Health Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003803032 PECOS PAC ID: 4486564952 Enrollment ID: O20031105000436 |
News Archive
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that diluted earnings per share equaled $0.39 in the first quarter of fiscal 2011. Excluding the charge related to the United States Department of Justice investigations described below, and a charge of $50.0 million, or $0.17 per share net of tax, for a new product licensing fee, non-GAAP earnings per share for the first fiscal quarter were $0.95 per share.
Humana Inc. alleges the device maker violated federal racketeering statutes by conspiring with prominent physicians to promote unapproved uses of the drug, reports The Wall Street Journal.
One of the problems faced by health officials today is the vast number of asymptomatic carriers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as they can still transmit the virus. Therefore the testing of as many people as possible is crucial for immediate isolation of cases to prevent the virus from spreading further.
The WHO and Roll Back Malaria partnership (RBM) on Wednesday launched an initiative to "stop a form of drug-resistant malaria from spreading from Southeast Asia to Africa, where millions of lives could be at risk," Reuters reports. "It would cost about $175 million a year to contain and prevent the global spread of the artemisinin-resistant parasite which first emerged along the Thai-Cambodian border in 2007, the United Nations agency said," according to the news agency (Nebehay, 1/12).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan Lee Wilson, MD 4141 5th St, Rapid City, SD 57701-6021 Ph: (605) 341-2424 | Dr Jonathan Lee Wilson, MD 4141 5th St, Rapid City, SD 57701-6021 Ph: (605) 341-2424 |
News Archive
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that diluted earnings per share equaled $0.39 in the first quarter of fiscal 2011. Excluding the charge related to the United States Department of Justice investigations described below, and a charge of $50.0 million, or $0.17 per share net of tax, for a new product licensing fee, non-GAAP earnings per share for the first fiscal quarter were $0.95 per share.
Humana Inc. alleges the device maker violated federal racketeering statutes by conspiring with prominent physicians to promote unapproved uses of the drug, reports The Wall Street Journal.
One of the problems faced by health officials today is the vast number of asymptomatic carriers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as they can still transmit the virus. Therefore the testing of as many people as possible is crucial for immediate isolation of cases to prevent the virus from spreading further.
The WHO and Roll Back Malaria partnership (RBM) on Wednesday launched an initiative to "stop a form of drug-resistant malaria from spreading from Southeast Asia to Africa, where millions of lives could be at risk," Reuters reports. "It would cost about $175 million a year to contain and prevent the global spread of the artemisinin-resistant parasite which first emerged along the Thai-Cambodian border in 2007, the United Nations agency said," according to the news agency (Nebehay, 1/12).
› Verified 3 days ago
Stuart Glen Rice, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 4141 5th St, Rapid City, SD 57701 Phone: 605-341-2424 Fax: 605-341-4547 | |
James F Nabwangu, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2805 5th St, Suite 100, Rapid City, SD 57701 Phone: 605-719-5650 Fax: 605-719-5655 | |
Dr. Rodney Mark Samuelson, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1635 Caregiver Cir, Rapid City, SD 57702 Phone: 605-755-6100 Fax: 605-755-6101 | |
Theodore G Obenchain, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2805 5th St, Rapid City, SD 57701 Phone: 605-719-5650 Fax: 605-719-5655 | |
Mark S Monasky, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2805 5th St, 100, Rapid City, SD 57701 Phone: 605-719-5700 Fax: 605-719-5701 | |
Larry L Teuber, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 9701 Clarkson Rd, Rapid City, SD 57702 Phone: 605-484-1616 Fax: 605-394-9307 |